Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00984620
What this trial is testing

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 160
Post-approval studies (Phase 4)Study completedNCT02609893
What this trial is testing

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs

Who this might be right for
Chronic Hepatitis C
Phillip Coffin, MD, MIA 31
Large-scale testing (Phase 3)Study completedNCT01498068
What this trial is testing

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Genotype 1 Chronic Hepatitis C
Janssen-Cilag International NV 36
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Not applicableLooking for participantsNCT01280825
What this trial is testing

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Who this might be right for
Patients Undergoing Routine Health CareHeart DiseasesInflammatory Bowel Diseases+5 more
University of Chicago 1,200
Large-scale testing (Phase 3)Study completedNCT02607735
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

Who this might be right for
Hepatitis C
Gilead Sciences 416
Testing effectiveness (Phase 2)Study completedNCT01749150
What this trial is testing

Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 61
Testing effectiveness (Phase 2)Study completedNCT02161952
What this trial is testing

Pirfenidone, an Antifibrotic and Antiinflammatory Drug

Who this might be right for
FibrosisHepatitis C Chronic
University of Guadalajara 150
Not applicableLooking for participantsNCT04493385
What this trial is testing

The Hepatitis C Transplant Collaborative

Who this might be right for
Transplant; Failure, HeartHepatitis C
Baylor Research Institute 500
Not applicableStudy completedNCT03402334
What this trial is testing

Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors

Who this might be right for
Hepatitis CAtherosclerosis
Tulane University 231
Early research (Phase 1)Study completedNCT00503347
What this trial is testing

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Who this might be right for
Hepatitis C VirusHiv Infections
Peregrine Pharmaceuticals 24
Not applicableStudy completedNCT02786758
What this trial is testing

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

Who this might be right for
Hepatitis CHIV
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00324389
What this trial is testing

Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT01423643
What this trial is testing

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 1,250
Not applicableUnknownNCT03941821
What this trial is testing

Glecaprevir/Pibrentasvir Real-world Study in China

Who this might be right for
Chronic Hepatitis c
Tongji Hospital 800
Early research (Phase 1)Study completedNCT00635804
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 60
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Large-scale testing (Phase 3)UnknownNCT02961426
What this trial is testing

Strategic Transformation of the Market of HCV Treatments

Who this might be right for
Hepatitis C
Drugs for Neglected Diseases 603
Post-approval studies (Phase 4)Study completedNCT03512210
What this trial is testing

Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

Who this might be right for
Hepatitis CHIV-1-infectionLiver Diseases
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 400
Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Next Page